Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 7, 2023
Event: Unregistered sale of equity securities and material modification to rights of security holders.
Key Financial Metrics
This filing reports a capital raise rather than operational financial results. Key metrics include:
- Gross Proceeds: $13.625 million.
- Securities Issued: 13,625 shares of Series A Convertible Preferred Stock.
- Purchase Price: $1,000 per share.
- Initial Conversion Price: $1.394 per share of Common Stock.
- Liquidity Impact: Immediate cash inflow of $13.625 million upon closing.
Note: The filing does not provide data on revenue, profit, operating cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the creation and sale of a new class of equity:
- Capital Structure: Issuance of Series A Preferred Stock, which ranks senior to Common Stock.
- Dividend Rights: Holders are entitled to dividends in the form of Common Stock equal to 20% of the shares issuable upon conversion, payable on March 7, 2024, and March 7, 2025.
- Automatic Conversion: The Series A Preferred Stock will automatically convert into Common Stock on March 7, 2025, subject to beneficial ownership limitations.
- Registration Rights: The Company executed a Registration Rights Agreement to file a registration statement for the resale of Common Stock issuable upon conversion.
Outlook, Risks, and Contingencies
- Beneficial Ownership Limitations: Conversions and dividend payments are restricted if they would cause a holder to beneficially own more than 4.99% (or 9.99% upon election) of the Company's outstanding Common Stock.
- Liquidation Preference: In a liquidation event, Series A holders are paid before Common Stockholders an amount equal to the greater of the Stated Value ($1,000) plus accrued dividends, or the value if converted immediately prior to the event.
- Voting Rights: Holders of Series A Preferred Stock generally have no voting rights unless otherwise required by law.
- Regulatory Status: The offering was exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the dilution impact on existing Common Stockholders upon the automatic conversion of Series A Preferred Stock in 2025.
- Review the full text of the Certificate of Designation (Exhibit 3.1) for specific beneficial ownership limitation mechanics.
- Confirm the timeline and status of the Registration Rights Agreement (Exhibit 10.1) for the resale of underlying Common Stock.
- Assess the Company's cash burn rate relative to the $13.625 million raised to determine runway extension.
- Check for any subsequent filings regarding the use of proceeds or changes in the Company's capital structure.